We tested a much higher dose of amylin (5 μg/mouse) or pramlintide (5 μg/mouse) at the same time as olanzapine (5 mg/kg) to determine if even higher pharmacological doses would be effective in protecting against olanzapine-induced hyperglycemia. This evidence concerns the gene IAPP and Hyperglycemia.